Related Experiment Video
Updated: Jun 3, 2026
13:33
Infinium Assay for Large-scale SNP Genotyping Applications
Published on: November 19, 2013
Pharmacogenetics: from bench to byte--an update of guidelines
J J Swen1, M Nijenhuis, A de Boer
1Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Clinical Pharmacology and Therapeutics
|March 18, 2011
Summary
Pharmacogenetic test results lack clear therapeutic guidelines. A working group developed evidence-based recommendations for 53 drugs linked to specific gene variants, improving personalized medicine.
Area of Science:
- Pharmacogenomics
- Clinical Pharmacy
- Genetics
Background:
- Limited clinical guidelines exist for translating pharmacogenetic test results into actionable therapeutic recommendations.
- This gap hinders the effective implementation of personalized medicine strategies.
Purpose of the Study:
- To establish pharmacogenetics-based therapeutic (dose) recommendations.
- To bridge the gap between genetic information and clinical practice.
Main Methods:
- A systematic literature review was conducted.
- Recommendations were developed for drugs associated with key pharmacogenetic genes.
Main Results:
- Recommendations were formulated for 53 drugs.
- These recommendations cover genes including CYP2D6, CYP2C19, CYP2C9, TPMT, DPD, VKORC1, UGT1A1, HLA-B44, HLA-B*5701, CYP3A5, and FVL.
Conclusions:
- The developed recommendations provide a foundation for integrating pharmacogenetics into routine clinical practice.
- This initiative aims to optimize drug therapy and patient outcomes based on genetic profiles.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...